Digoxin Mnemonic - Cardiac Glycosides (Inotropes) - Cardiac Pharmacology - Cardiology

Summary

This video from Medicosis Perfectionatus offers a thorough, engaging breakdown of digoxin, a cardiac glycoside used to boost heart contractility and manage certain arrhythmias. The instructor explains its mechanisms, including inhibition of the sodium-potassium ATPase pump and effects on calcium levels, while highlighting its role in systolic heart failure and contraindications like Wolff-Parkinson-White syndrome. Key pharmacological details, potential side effects, and toxicity management with DigiBind are covered, along with tips on EKG changes and clinical use. Presented in a lively, mnemonic-driven style, the video simplifies complex cardiac pharmacology concepts, making them easier to understand and remember for medical learners.

Takeaways

• 💊 Digoxin is a cardiac glycoside, part of the digitalis family, including Digitoxin, Digoxin, and Dioxin.
• ❤️ Digoxin increases cardiac contractility, making it useful in **systolic heart failure** (reduced ejection fraction).
• ⏱️ Digoxin slows conduction through the AV node, decreasing heart rate, which helps in atrial fibrillation, atrial flutter, and PSVT.
• ⚠️ Digoxin is contraindicated in **Wolff-Parkinson-White (WPW) syndrome** because it can worsen tachyarrhythmias by favoring the accessory pathway.
• 🔬 Mechanism: Digoxin inhibits the **Na⁺/K⁺ ATPase**, leading to increased intracellular Na⁺, which reduces Na⁺/Ca²⁺ exchange and increases intracellular Ca²⁺, boosting contractility.
• 🧠 Digoxin does **not reduce mortality** in heart failure or post-MI; it only improves symptoms.
• ⏳ Pharmacokinetics: Digoxin has a **large volume of distribution**, requires a **loading dose**, has a **delayed onset**, and is easily displaced by other drugs.
• ⚡ Toxicity: Can cause disorientation, visual disturbances (yellow-green halos), arrhythmias, and EKG changes (ST depression, QT shortening).
• 🛡️ Antidote: **DigiBind** (anti-digoxin antibodies) binds digoxin and reduces toxicity.
• 📝 Key mnemonic: Digoxin **D**estroys Na⁺/K⁺ ATPase → ↑ Ca²⁺ → ↑ contractility; slows AV conduction → ↓ heart rate; does not lower mortality; toxicity treated with DigiBind.
• 💡 Digoxin is **useful for chronic management**, but not ideal for acute heart failure—use drugs like **dobutamine** instead.

Q & A

What class of medication does digoxin belong to?

Digoxin belongs to the class of cardiac glycosides, also known as digitalis.

What are the two main therapeutic purposes of digoxin?

Digoxin is used to boost cardiac contractility in systolic heart failure and to delay conduction at the atrioventricular (AV) node to control heart rate in certain arrhythmias.

In which type of heart failure is digoxin indicated?

Digoxin is indicated in systolic heart failure, where the heart fails to contract effectively, because it increases the force of cardiac contraction.

Why is digoxin contraindicated in Wolff-Parkinson-White (WPW) syndrome?

In WPW, there is an accessory pathway that bypasses the AV node. Slowing the AV node with digoxin allows impulses to travel preferentially through the faster accessory pathway, which can worsen tachyarrhythmias.

Which drugs that slow AV node conduction are contraindicated in WPW syndrome?

Adenosine, beta blockers, calcium channel blockers, and digoxin are all contraindicated in WPW because they slow the AV node and can worsen arrhythmias.

How does digoxin increase cardiac contractility at the cellular level?

Digoxin inhibits the sodium-potassium ATPase pump, causing intracellular sodium accumulation. This impairs the sodium-calcium exchanger, leading to increased intracellular calcium, which enhances cardiac contractility.

How does digoxin affect the AV node and heart rate?

Digoxin delays conduction through the AV node, which reduces the ventricular rate, especially useful in controlling supraventricular tachyarrhythmias.

Does digoxin improve mortality in patients with congestive heart failure or after myocardial infarction?

No, digoxin does not lower mortality or increase survival; it primarily improves symptoms and quality of life in heart failure.

What is the antidote for digoxin toxicity?

The antidote is DigiFab (anti-digoxin antibody fragments), which bind digoxin, neutralize its effects, and facilitate its elimination from the body.

Why is digoxin not suitable for acute heart failure?

Digoxin has a delayed onset of action due to its large volume of distribution and protein binding, so it is not effective for immediate relief in acute heart failure; fast-acting drugs like dobutamine are preferred.

What are some notable side effects of digoxin?

Common side effects include disorientation, visual disturbances such as yellow-green halos, ST-segment depression, and decreased QT interval on ECG.

How does digoxin affect the action potential in ventricular muscle cells?

Digoxin slows phase 0 of the ventricular action potential by decreasing the slope of rapid sodium influx, which reduces conduction velocity and may predispose to re-entrant arrhythmias if unevenly distributed.